Seres Therapeutics Inc
MCRB
Market Cap$88.22M
Close$
$3.49
462.3% upside
Current Fair Value
462.3% upsideUndervalued by 462.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $88.22 Million |
|---|---|
| Enterprise Value | $61.80 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.89 |
| Beta | 0.54 |
| Outstanding Shares | 151,009,462 |
| Avg 30 Day Volume | 3,873,018 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.78 |
|---|---|
| PEG | 1.94 |
| Price to Sales | - |
| Price to Book Ratio | -0.62 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | -0.57 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.64 |
| Debt to Equity | -2.26 |
Revenue Sources
No data
ESG Score
No data
About Seres Therapeutics Inc
CEO: Eric Shaff